Results 81 to 90 of about 1,356,506 (200)

The Safety and Efficacy of Absnow Fully Biodegradable Atrial Septal Defect Occluder: A Prospective, Single‐Center Phase III Clinical Trial

open access: yesClinical Cardiology, Volume 49, Issue 2, February 2026.
ABSTRACT Objective To evaluate the safety, short‐term and mid‐term occlusion performance of the Absnow fully biodegradable atrial septal occluder in pediatric patients. Background The Absnow Occluder, an innovative fully biodegradable closure for ASD, has shown its safety and effectiveness in initial animal studies and preclinical trials.
Shiqiang Fan   +7 more
wiley   +1 more source

Cryoablation of pulmonary veins in a patient with an atrial septal occluder and atrial fibrillation: A case report

open access: yesHeart Vessels and Transplantation
Objective: An atrial septal defect (ASD) is one of the most common congenital heart defects and is associated with an increased risk of atrial arrhythmias.
Ayan Abdrakhmanov   +3 more
doaj   +1 more source

Penetration of left and right atrial wall and aortic root by an Amplatzer atrial septal occluder in a nine year old boy with Marfan syndrome: Case report

open access: yesJournal of Cardiothoracic Surgery, 2008
Background To describe complications associated with Amplatzer septal occluders in a patient with Marfan syndrome Case presentation A nine-year-old boy with Marfan syndrome and a 22 mm atrial septal defect (ASD) was treated successfully by interventional
Schlensak Christian   +2 more
doaj   +1 more source

Circular Loop Ligation for Securing Endobronchial Valve in the Treatment of Bronchial Stump Fistula

open access: yesCanadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Background Bronchial stump fistula (BSF), which is located on the bronchial stump following pulmonary resection, represents a distinct subtype of bronchopleural fistula (BPF). Although the endobronchial valve (EBV) has been used to treat BPF, few clinical studies involve BSF occluded by EBV because the abnormal bronchial stump makes EBV implantation ...
Liping Wang   +6 more
wiley   +1 more source

Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device

open access: yes, 2015
Cobrahead deformity is a known (but uncommon) phenomenon associated with the left atrial disc of the AMPLATZER or Occlutech Figulla septal occluder device during percutaneous transcatheter atrial septal defect closure.
ŞAHİN, TAYFUN   +2 more
core   +1 more source

Comparison of a Novel Occluder Versus Traditional Occluder in Atrial Septal Defect: A Randomized Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Traditional occluders for atrial septal defect have 2 drawbacks: incomplete endothelialization and difficulty in achieving atrial septum puncture post implantation. The novel occluder ReAces was designed to address these 2 clinical pain points.
Yanxing Fang   +9 more
doaj   +1 more source

Safety and Feasibility of a Novel Split Design Left Atrial Appendage Occluder: From Preclinical Investigations to First‐in‐Human Application

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Objective This study was designed to first evaluate the histological compatibility of the split occluder in preclinical animal models, followed by clinical validation of its procedural feasibility and occlusion effectiveness in a first‐in‐human trial cohort. Methods Eight healthy labrador retrievers were selected for this study.
Mingfei Li   +8 more
wiley   +1 more source

Unexpected difficulty during transcatheter device closure of atrial septal defect associated with right aortic arch

open access: yesAnnals of Pediatric Cardiology, 2012
Right aortic arch (RAA) associated with isolated atrial septal defect (ASD) is very rare. We report successful closure of ASD associated with RAA using a 26-mm atrial septal occluder in a 30-year-old male patient.
Nageswara Rao Koneti   +3 more
doaj   +1 more source

A multicentre, comparative study of Cera septal occluder versus AMPLATZER Septal Occluder in transcatheter closure of secundum atrial septal defects

open access: yes, 2014
Aims: To evaluate the safety and efficacy of the new Cera septal occluder (CSO) for atrial septal defect (ASD) closure as compared to the AMPLATZER Septal Occluder (ASO)
Meric, Murat   +7 more
core   +1 more source

In Hospital Complications of Atrial Septal Defect Device Closure at Shahid Gangalal National Heart Centre, Kathmandu, Nepal

open access: yesJournal of Nepal Health Research Council, 2020
Background: Atrial deptal defect device closure has become the preferred method in the treatment of atrial septal defect. We aim to study the in-hospital complications of atrial septal defect device closure procedure.
Chandra Mani Adhikari   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy